Zimmer Biomet Holdings Inc’s recently made public that its Group President, Asia Pacific Yi Sang unloaded Company’s shares for reported $74011.0 on Jun 13 ’25. In the deal valued at $92.51 per share,800 shares were sold. As a result of this transaction, Yi Sang now holds 19,624 shares worth roughly $1.82 million.
Then, Yi Sang sold 1,000 shares, generating $95,000 in total proceeds. Upon selling the shares at $95.00, the Group President, Asia Pacific now owns 20,424 shares.
Before that, Yi Sang bought 800 shares. Zimmer Biomet Holdings Inc shares valued at $74,011 were divested by the Officer at a price of $92.51 per share.
Roth Capital upgraded its Zimmer Biomet Holdings Inc [ZBH] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in mid December from “a Neutral” to “an Overweight”. Wolfe Research began covering ZBH with “Peer perform” recommendation on September 10, 2024. Piper Sandler revised its rating on July 01, 2024. It rated ZBH as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of ZBH
On Monday, Zimmer Biomet Holdings Inc [NYSE:ZBH] saw its stock fall -0.64% to $92.59. Over the last five days, the stock has lost -1.35%. Zimmer Biomet Holdings Inc shares have fallen nearly -16.62% since the year began. Nevertheless, the stocks have fallen -12.34% over the past one year.
How much short interest is there in Zimmer Biomet Holdings Inc?
A steep rise in short interest was recorded in Zimmer Biomet Holdings Inc stocks on 2025-06-13, growing by 0.47 million shares to a total of 6.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 5.95 million shares. There was a rise of 7.31%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 30, 2024 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $129 price target.
